Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
92 hedge funds and large institutions have $792M invested in Portola Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 10 closing their positions.
230% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 10
217% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 12
46% more capital invested
Capital invested by funds: $542M → $792M (+$250M)
33% more funds holding
Funds holding: 69 → 92 (+23)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$118M |
| 2 |
JP Morgan Chase
New York
|
+$25.3M |
| 3 |
SG Americas Securities
New York
|
+$23.8M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$18.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$43.4M |
| 2 |
D.E. Shaw & Co
New York
|
-$5.91M |
| 3 |
Goldman Sachs
New York
|
-$4.36M |
| 4 |
Millennium Management
New York
|
-$3.24M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.73M |
PTLA Hedge Fund Activity: Q4 2013 in Review
92 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q4 2013, worth a combined $792M — up 46% from $542M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new PTLA positions and 10 closed out — a net gain of 23 holders — while 38 added to existing stakes and 12 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $118M. The largest seller was Bain Capital Public Equity Management, cutting an estimated $43.4M.
- 92 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q4 2013, up from 69 in Q3 2013.
- Funds reported $792M of Portola Pharmaceuticals, Inc. stock for Q4 2013, up 46% quarter-over-quarter.
- 33 funds opened new Portola Pharmaceuticals, Inc. positions in Q4 2013 and 10 closed out, a net change of +23 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q4 2013 was Wellington Management Group, an estimated $118M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q4 2013 was Bain Capital Public Equity Management, an estimated $43.4M sold.
Based on aggregated 13F filings for Q4 2013.